An interventional study of Pectoral Nerve Block and Pectoral Nerve Block in Postoperative Pain, sponsored by Sargodha Medical College. Completed at 1 site in Pakistan. Open to participants aged 20 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-10.
Sponsored by Sargodha Medical College · Not applicable, Interventional, and Supportive care
Among 134 studies in Pain, Postoperative with a site in Pakistan — 38 open to participants now, 41 under way, 5 of them phase 3. Pain, Postoperative · Pakistan.
Among the 134 studies in Pain, Postoperative with a site in Pakistan, this one is the 90th largest by enrollment of the 132 interventional ones that give a count, is one of 22 that started in 2026, is one of 83 with no phase, and was the 120th registered.
5,640 studies on the registry are indexed under Pain, Postoperative; 1,230 are open to participants now.
Browse Pain, Postoperative studies →38 of the 134 studies in Pain, Postoperative with a site in Pakistan are open now. Recruiting first, the newest first:
Shaukat Khanum Memorial Cancer Hospital & Research Centre · Sites in Pakistan
Ages 18+
Wah Medical college , POF hospital · Sites in Pakistan
Ages 18–60
King Edward Medical University · Sites in Pakistan
Ages 18–60
Quaid-e-Azam Medical College · Sites in Pakistan
Ages 1–15
Sindh Institute of Urology and Transplantation · Sites in Pakistan
Ages 18–70 · Women only
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 679 Pain, Postoperative studies recruiting now, 241 (35%) set no upper age limit and 328 (48%) stop at 75 or younger; 74 take children under 18; 128 take healthy volunteers.
This study: 20 Years to 70 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
134 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 12 · Phase 2 13 · Phase 3 13 · Phase 4 20
First in 2014; this study’s year is marked. 22 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 62 is below the median of 75 across 4,821 interventional studies indexed under Pain, Postoperative.
Median enrollment 79 across the 132 interventional studies, 60 across the 2 observational. Of the 78 that completed or were terminated, 3 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 134 has an industry lead sponsor. The 10 most frequent:
Sargodha Medical College is the lead sponsor of 13 studies on the registry; 5 are open to participants now.
Sargodha Medical College has 4 studies filed under Pain, Postoperative — fewer than ten, so there is no comparison to draw.
12 of the studies in Pain, Postoperative with a site in Pakistan that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06996561Phase 3Dr. Asma Abdus SalamExploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management | 2027-01-01 |
| NCT07779551Sargodha Medical CollegeComparison of Two Drugs Bupivacaine and Ropivacaine for Postoperative Analgesia in Bilateral Superficial Cervical Plexus Block After Thyroidectomy | 2026-12 |
| NCT07650760Wah Medical college , POF hospitalComparison of Intraperitoneal Bupivacaine and Saline Irrigation for Pain Relief After Laparoscopic Cholecystectomy | 2026-12 |
| NCT07338006University of Health Sciences LahoreChest Wall Reconstruction Cohort | 2026-12-31 |
| NCT07747584Allied Hospital FaisalabadEffect of Local Anesthetic Infiltration for Postoperative Pain Control in Laparoscopic Abdominal Surgery: A Prospective Randomized Study | 2027-01 |
Among the 134 studies in Pain, Postoperative with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
In this study the investigators will compare the post operative opoid consumption for patient undergoing modified radical mastectomy. The patients will be divided into two groups one group will receive modified pectoral nerve block with local anesthetic ropivacaine combined with tramadol and other group will receive pectoral nerve block with ropivacaine only
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Procedure: Pectoral Nerve Block
Procedure: Pectoral Nerve Block
One group will receive ropivacaine with tramadol in modified pectoral nerve block
This group will receive ropivacaine only.
Postoperative Pain with visual analogue scale
Post operatively pain will be accessed by visual analogue scale . Visual analogue scale (VAS) scale has score from 0 to 10 where 0 score indicate no or minimal pain and score of 10 indicate worst possible pain.
Time frame: 24 hours postoperatively
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2026 to primary completion in Mar 2026, 1 month.
Of 2,089 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 1 month is below that.
Counting every sponsor, half of 2,102 studies reached it within 11 months; a quarter within 6 and three quarters within 23.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: primary completion Aug 2027 → Mar 2026 and completion Aug 2027 → Mar 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sargodha Medical College